I'm curious, was Titan Pharmaceuticals mentioned? I was invested in them years ago when they were attempting to get their subcutaeous opioid treatment approved and got the same slow walk FDA treatment we're getting here. A CRL letter to delay approval for more than a year while a sub-lingual version of Suboxone got rushed through. Titan's product was tamper-proof to prevent illegal selling among addicts, while the other was not. Bupreorphine, the Titan product eventually got approved but bad mgmt and a horrible rollout left it in the dustbin, while the epidemic rages on.